Bioatla Stock Alpha and Beta Analysis
| BCAB Stock | USD 0.57 0.15 20.83% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Bioatla. It also helps investors analyze the systematic and unsystematic risks associated with investing in Bioatla over a specified time horizon. Remember, high Bioatla's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Bioatla's market risk premium analysis include:
Beta (1.49) | Alpha 0.65 | Risk 9.86 | Sharpe Ratio 0.063 | Expected Return 0.62 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Bioatla Backtesting, Bioatla Valuation, Bioatla Correlation, Bioatla Hype Analysis, Bioatla Volatility, Bioatla History and analyze Bioatla Performance. Bioatla Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Bioatla market risk premium is the additional return an investor will receive from holding Bioatla long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bioatla. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Bioatla's performance over market.| α | 0.65 | β | -1.49 |
Bioatla expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Bioatla's Buy-and-hold return. Our buy-and-hold chart shows how Bioatla performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Bioatla Market Price Analysis
Market price analysis indicators help investors to evaluate how Bioatla stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bioatla shares will generate the highest return on investment. By understating and applying Bioatla stock market price indicators, traders can identify Bioatla position entry and exit signals to maximize returns.
Bioatla Return and Market Media
The median price of Bioatla for the period between Thu, Oct 2, 2025 and Wed, Dec 31, 2025 is 0.78 with a coefficient of variation of 15.77. The daily time series for the period is distributed with a sample standard deviation of 0.12, arithmetic mean of 0.78, and mean deviation of 0.09. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Why BioAtla Inc. stock is a value investor pick - Weekly Risk Summary Advanced Technical Signal Analysis - Fundao Cultural do Par | 10/28/2025 |
2 | How supply chain issues affect BioAtla Inc. stock - July 2025 Setups Consistent Growth Equity Picks - newser.com | 11/04/2025 |
3 | BioAtlas Mecbotamab Vedotin , an AXL-targeting ADC, Demonstrates a Median Overall Survival of 21.5 months in Subtypes of Refractory Soft Tissue Sarcomas | 11/07/2025 |
4 | Disposition of 12530 shares by Sievers Eric of Bioatla at 0.46 subject to Rule 16b-3 | 11/11/2025 |
5 | Whats Next BioAtlas Earnings Preview | 11/12/2025 |
6 | BioAtla, Inc. Q3 2025 Earnings Call Transcript | 11/14/2025 |
7 | BioAtla Enters into Agreements for up to 22.5 Million Flexible Financing - Investing News Network | 11/20/2025 |
8 | Can BioAtla Inc. stock rebound after recent weakness - Market Rally Low Risk Growth Stock Ideas - B NI V | 11/26/2025 |
9 | Disposition of 1566 shares by Christian Vasquez of Bioatla at 0.904 subject to Rule 16b-3 | 11/28/2025 |
10 | BioAtla, Inc. Short Interest Down 29.9 percent in December | 12/30/2025 |
About Bioatla Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Bioatla or other stocks. Alpha measures the amount that position in Bioatla has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2024 | 2025 (projected) | Interest Debt Per Share | 0.1 | 0.0172 | 0.0164 | Revenue Per Share | 0.23 | 0.26 | 0.2 |
Bioatla Upcoming Company Events
As portrayed in its financial statements, the presentation of Bioatla's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bioatla's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Bioatla's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Bioatla. Please utilize our Beneish M Score to check the likelihood of Bioatla's management manipulating its earnings.
| 28th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Bioatla
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Bioatla Backtesting, Bioatla Valuation, Bioatla Correlation, Bioatla Hype Analysis, Bioatla Volatility, Bioatla History and analyze Bioatla Performance. For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Bioatla technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.